The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.84
Bid: 0.842
Ask: 0.852
Change: 0.00 (0.00%)
Spread: 0.01 (1.188%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.84
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

1 Aug 2023 11:29

RNS Number : 9344H
BioPharma Credit PLC
01 August 2023
 

BioPharma Credit plc

(the "Company")

TOTAL VOTING RIGHTS

 

In conformity with the Disclosure Guidance and Transparency Rules, the Company notifies the market that the issued share capital and voting rights of the Company, as at 31 July 2023, were as follows:

 

Class of share

Total number of shares in circulation

Number of voting rights attached to each share

Total number of voting rights of shares in circulation

Number of shares held in treasury (carrying no voting rights attached until issued)

Total number of shares in issue

Ordinary $0.01 shares

1,302,679,192

1

1,302,679,192

71,252,875

1,373,932,067

 

The above total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in BioPharma Credit PLC under the FCA's Disclosure Guidance and Transparency Rules.

 

1 August 2023

 

 

LEI: 213800AV55PYXAS7SY24

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREAEPFEAPDEFA
Date   Source Headline
22nd Mar 20237:00 amRNSAnnual Financial Report
13th Mar 20237:00 amRNSSTATEMENT REGARDING SILICON VALLEY BANK
1st Mar 20237:00 amRNSNOTICE OF FULL YEAR RESULTS
21st Feb 20234:00 pmRNSNet Asset Value(s) and Monthly Factsheet
1st Feb 20232:00 pmRNSTotal Voting Rights
23rd Jan 20234:00 pmRNSNet Asset Value(s) and Monthly Factsheet
9th Jan 20236:15 pmRNSTransaction in Own Shares
3rd Jan 20235:28 pmRNSTotal Voting Rights
29th Dec 20226:15 pmRNSTransaction in Own Shares
21st Dec 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
20th Dec 20226:15 pmRNSTransaction in Own Shares
16th Dec 20226:15 pmRNSTransaction in Own Shares
15th Dec 20226:15 pmRNSTransaction in Own Shares
14th Dec 20226:15 pmRNSTransaction in Own Shares
13th Dec 20226:15 pmRNSTransaction in Own Shares
12th Dec 20226:15 pmRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSTotal Voting Rights
21st Nov 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Nov 20227:00 amRNSNEW INVESTMENT OF UP TO US$50.0 MILLION
15th Nov 20226:15 pmRNSTransaction in Own Shares
14th Nov 20226:15 pmRNSTransaction in Own Shares
11th Nov 20226:15 pmRNSTransaction in Own Shares
10th Nov 20226:15 pmRNSTransaction in Own Shares
9th Nov 20226:15 pmRNSTransaction in Own Shares
8th Nov 20226:15 pmRNSTransaction in Own Shares
7th Nov 20226:15 pmRNSTransaction in Own Shares
7th Nov 20227:00 amRNSUPDATES TO THE DISCOUNT CONTROL MECHANISM
4th Nov 20226:15 pmRNSTransaction in Own Shares
4th Nov 20223:26 pmRNSEdison issues review on BioPharma Credit (BPCR)
3rd Nov 20226:15 pmRNSTransaction in Own Shares
1st Nov 20224:37 pmRNSTotal Voting Rights
31st Oct 20226:15 pmRNSTransaction in Own Shares
28th Oct 20226:15 pmRNSTransaction in Own Shares
26th Oct 20226:15 pmRNSTransaction in Own Shares
25th Oct 20226:15 pmRNSTransaction in Own Shares
24th Oct 20226:15 pmRNSTransaction in Own Shares
24th Oct 20224:38 pmRNSDirector/PDMR Shareholding
24th Oct 20224:37 pmRNSDirector/PDMR Shareholding
21st Oct 20226:15 pmRNSTransaction in Own Shares
20th Oct 20226:15 pmRNSTransaction in Own Shares
20th Oct 20227:00 amRNSNew US$140.0 Million Investment
18th Oct 20226:15 pmRNSTransaction in Own Shares
17th Oct 20226:15 pmRNSTransaction in Own Shares
14th Oct 20226:15 pmRNSTransaction in Own Shares
14th Oct 20225:44 pmRNSHolding(s) in Company
13th Oct 20226:15 pmRNSTransaction in Own Shares
13th Oct 20227:00 amRNSSPECIAL DIVIDEND DECLARATION AND NET ASSET VALUES
7th Oct 20226:15 pmRNSTransaction in Own Shares
6th Oct 20226:29 pmRNSTransaction in Own Shares
6th Oct 20227:00 amRNSStatement re Global Blood Therapeutics, Inc.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.